期刊文献+

度洛西汀与西酞普兰治疗老年抑郁症的对照研究 被引量:3

Comparative study of Duloxetine and Citalopram in the treatment of senile depression
在线阅读 下载PDF
导出
摘要 目的:比较度洛西汀和西酞普兰治疗老年抑郁症的疗效及安全性。方法:对66例老年抑郁症患者随机分为度洛西汀组和西酞普兰组,疗程6周。采用汉密尔顿抑郁量表(HAMD)和治疗中出现的症状量表(TESS)在治疗前及治疗1、2、4、6周评定疗效和不良反应。结果:两组治疗后各时段HAMD评分均较治疗前明显下降(P均(0.01)。两组疗效差异无统计学意义(P>0.05)。两组不良反应比较无显著性差异(P>0.05)。结论:度洛西汀是一种安全有效的抗抑郁药,可用于老年抑郁症患者。 Objective:To compare the efficacy and safety of Duloxetine and Citalopram in the treatment of senile depression. Methods :66 patients with senile depression were randomly divided into Duloxetine group and Citalopram group for 6 week treatment. Hamilton depression scale (HAMD) and treatment emergent symptom scale (TESS) were used to evaluate the clinical efficacy and safety, before treatment and 1, 2, 4,6week after treatment. Results: The score of HAMD reduced significantly after every treatment time in two groups (both P 〈 0.01 ). There were no significant differences in the efficacy and adverse events between the two groups. Conclusions: Duloxetine is an effective and safe antidepressant in the treatment of senile depression.
出处 《中国民康医学》 2010年第11期1367-1367,1369,共2页 Medical Journal of Chinese People’s Health
关键词 度洛西汀 西酞普兰 老年抑郁症 Duloxetine Citalopram Senile depression
  • 相关文献

参考文献7

二级参考文献23

  • 1栗大顺,于建新,庞月岱.西酞普兰与文拉法辛治疗抑郁症的对照研究[J].临床精神医学杂志,2005,15(3):158-159. 被引量:33
  • 2赵静,朱珠.度洛西汀临床应用的安全性[J].药物不良反应杂志,2005,7(4):304-306. 被引量:13
  • 3范建华,邹清兰,杨峰一.西酞普兰与氟西汀治疗抑郁症的对照研究[J].山东精神医学,2005,18(4):265-266. 被引量:13
  • 4国效峰,赵靖平,陈晋东.度洛西汀:一种新型抗抑郁药[J].中国新药与临床杂志,2006,25(7):552-555. 被引量:89
  • 5中华医学会精神科分会.中国精神障碍分类与诊断标准(CCMD-3)[M](第3版)[M].济南:山东科学技术出版社,2001.160-162.
  • 6Brown SL.Antidepressant use in the elderly:association with demographic characteristics,health-related factors,and health care utilization[J].J Clin Epidemiol,1995,48:445-453.
  • 7Nolan L.Adverse effects of antidepressant in the elderly[J].Drugs Aging,1992,2:450-458.
  • 8Patris M,Bouchard JM,Bougerol T,et al.Gitaopram versus fluoxetine:a double-blind,controlled,muticentre,phase Ⅲ trial inpatients with unipolar major depression treated in general practice[J].Int clin psychopharmacol,1996,11:129-136.
  • 9Lantz RJ,Gillespie TA,Rash TJ,et al.Metabolism,exeretion,and pharmacokinetics of duloxetine in healthy human subjects[J].Drug Metabolism and Dispostition,2003,31:1142-1150.
  • 10Pmskom SH.Duloxetine[J].J Psychiatr Pract,2004,10:375-385.

共引文献216

同被引文献38

  • 1国效峰,赵靖平,陈晋东.度洛西汀:一种新型抗抑郁药[J].中国新药与临床杂志,2006,25(7):552-555. 被引量:89
  • 2ANATHEA B W, PETER K. Duloxetine hydrochloride [ J ]. Nat Rev ,2004,3 ( 11 ) :907-908.
  • 3HIRSCHFELD R M, MALLINEKRODT C, LEE T C,et al. Time course of depression-symptom improvement during treatment with duloxetine [ J]. Depress Anxiety, 2005. 21 (4) :170-177.
  • 4PERAHIA D C, WANG F, ERL W, et al. Duloxetine in the treatment of major depressive disorder: a placebo-and paroxetine-controlled trial [ J ]. Eur Psychiatry, 2006, 21 (6) :367-378.
  • 5BAILEY R K,MALLINCKRODT C H,WOHLREICH M M, et al. Duloxetine in the treatment of major depressive disorder : comparison of safety and efficacy [ J ]. J Natl Med Assoc,2006,98 ( 3 ) :437-447.
  • 6NIERENBERG A A,GREIS J H, MALI.INCKRODT C H,et al. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder:one-set of antidepressant action, a non-inferiority study [ J ]. Curr Med Res Opin,2007 ,23( 2 ) :401-416.
  • 7Detke MJ, Lu Y, Goldstein DJ, et al. Duloxetine,60 mg once daily, for major depressive disorder:a double - blind placebo - controlled trial[ J]. J Clin Psychiatry,2002,63 (4) :308 - 315.
  • 8Goldstein DJ,Mallinckrodt C,Lu Y, et al. Duloxetine in the treat- ment of major depressive disorder : a double - blind clinical trial [ J ]. J Clin Psychiatry, 2002,63 ( 3 ) :225 - 231.
  • 9钱敏才,林敏,沈鑫华,钟华,朱毅平,杨剑虹.度洛西汀与文拉法辛对首发抑郁症疗效的对照研究[J].上海精神医学,2008,20(5):292-294. 被引量:32
  • 10赵青霞.度洛西汀与文拉法辛治疗抑郁症临床对照研究[J].中国民康医学,2008,20(23):2779-2780. 被引量:10

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部